Sukhtian Ghiath M.'s Form 4 filing
Outlook Therapeutics, Inc. (OTLK) · filed Dec 1, 2021
- Accession no.
- 0000947871-21-001250
- Filed
- Dec 1, 2021, 7:32 PM ET
- Trade date
- Nov 29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $20.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sukhtian Ghiath M.CIK 0001717441 | Director, 10% Owner |
| GMS Ventures & InvestmentsCIK 0001804598 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | Common Stock | PPurchaseAcquired | +16,000,000 | $1.25 | +$20,000,000 | 27,834,257 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.